Ms. Louise Pong is a pharmacist who is specialized in Oncology in Nashua, New Hampshire. Patients can reach her at 172 Kinsley St, Nashua or contact her on 603-595-3090. Active license number of Ms. Louise Pong is R1624 for Oncology in New Hampshire. Ms. Louise Pong is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Ms. Louise Pong speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Ms. Louise Pong
Specialization:
Oncology
Credentials:
RPH
Gender:
Female
Location:
172 Kinsley St, Nashua, New Hampshire, 03060-3648
Phone:
603-595-3090
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Ms. Louise Pong are as mentioned below.
NPI Number:
1851592448
NPI Enumeration Date:
30 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ms. Louise Pong are as mentioned below.
Specialization
License Number
State
Status
Oncology
R1624
New Hampshire
Primary
Oncology
18425
Massachusetts
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3 Patriot Cir, Bedford, Massachusetts
Zip:
01730-2437
Phone Number:
--
Fax Number:
--
Patients can reach Ms. Louise Pong at 172 Kinsley St, Nashua, New Hampshire or can call on phone at 603-595-3090.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.